Please fill out the form below and we will gladly respond as soon as possible.
A new case report published in the World Journal of Surgical Oncology explored an innovative reconstruction technique for rare soft tissue sarcomas of the hand and foot, including synovial sarcoma. The study was authored by Naoya Terao, Naoki Oike, Takashi Ariizumi, and colleagues, with research conducted primarily through the Division of Orthopedic Surgery at Niigata […]
A new multi-center retrospective study from three major U.S. sarcoma centers has analyzed outcomes in patients with localized synovial sarcoma, making it one of the largest modern cohorts to examine how tumor characteristics and treatment modality affect recurrence and survival in this disease. The study, led by Stefano Testa, Maggie Yuxi Zhou, and colleagues from […]
New industry analyses project continued growth in the North America synovial sarcoma treatment market, with a predicted compound annual growth rate (CAGR) of 4.2% from 2026 to 2033. The report reflects increasing momentum in rare cancer research, including advances in targeted therapy, immunotherapy, and precision medicine for synovial sarcoma. What’s Driving Growth in Synovial Sarcoma […]
We are incredibly honored to share that the Synovial Sarcoma Foundation received First Place in the Advocacy in Action Award at the 16th Annual SPAGN Conference in Stockholm, Sweden. Hosted by the Sarcoma Patient Advocacy Global Network (SPAGN), this award recognizes advocacy initiatives making a meaningful impact for sarcoma patients, families, clinicians, and researchers around […]
Developing treatments for rare cancers like synovial sarcoma remains one of the biggest challenges in modern medicine—but recent progress shows what’s possible. One major milestone came with the FDA approval of Tecelra, the first engineered T-cell therapy approved for a solid tumor in the U.S., including synovial sarcoma. Why Rare Cancers Face Unique Challenges Synovial […]
A recent case report highlights a rare GLI1-altered mesenchymal tumor presenting in the pleura (lining of the lung), a location where tumors can closely resemble synovial sarcoma. This case underscores a critical challenge in rare cancers — different tumors can appear similar under imaging and even under the microscope, making accurate diagnosis essential for appropriate […]
Advances in cell therapy for synovial sarcoma are creating more treatment options for patients with advanced disease. A recent update from Penn Medicine highlights the growing role of T-cell therapies in treating rare cancers like synovial sarcoma. What Is Afami-cel? Afamitresgene autoleucel (afami-cel) is the first FDA-approved T-cell receptor (TCR) therapy for adults with advanced […]
Synovial sarcoma is a rare soft tissue cancer that usually develops near joints in the arms or legs. However, in very rare cases, it can appear in unexpected places — including the pericardium, the lining around the heart. A recent case report describes a 23-year-old patient diagnosed with primary pericardial synovial sarcoma, an extremely uncommon […]
Synovial sarcoma is a rare soft tissue cancer that most commonly develops near the joints of the arms or legs. In extremely rare cases, it can arise in unexpected locations — including the heart. A recent case report highlights primary cardiac synovial sarcoma, an exceptionally uncommon presentation that underscores the complexity of diagnosing and treating […]
Recent industry analyses show that the synovial sarcoma clinical trial pipeline is expanding, with more than 15 companies developing over 20 investigational therapies aimed at improving treatment options for this rare cancer. Although synovial sarcoma remains difficult to treat, the growing number of clinical trials reflects increasing research investment and scientific focus on this disease. […]
